DNLI

Denali Therapeutics Inc.

Phase 2 AI-extracted

BIIB122

Parkinson’s disease

Resolved

7days ago

Phase 2 readout · ~ Jun 30, 2026 estimated

What's at stake Phase 2 trial results for BIIB122 in Parkinson’s disease are due ~ Jun 30, 2026. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · SEC 8-K verified 16h ago

“A clinical data readout of the global Phase 2b LUMA study of BIIB122 for early-stage Parkinson’s disease is expected in mid-2026.”

Add to calendar Post on X Reddit

Provenance